Orrum and LivaNova Partner on Medical Device Analytics

- Orrum Clinical Analytics was founded by perfusionists to address challenges in collecting and analyzing surgical data; its CŌRE Insights platform is built on a modern data stack using Snowflake and a managed dbt core environment to handle security and scalability for sensitive patient information. - The LivaNova Essenz Perfusion System, which received FDA 510(k) clearance in March 2023, is designed for data-driven care, with a central cockpit and patient monitor that records and displays real-time perfusion data from integrated sensors. - LivaNova, formed by a 2015 merger of Italy's Sorin S.p.A. and the US's Cyberonics Inc., employs a "razor-and-blade" business model for its cardiopulmonary division, selling capital equipment like the Essenz system to drive recurring revenue from associated high-margin disposables. - A key component of the Essenz system is the In-Line Blood Monitor (ILBM), which utilizes B-Capta™ sensing technology and is the only system of its kind compliant with Clinical Laboratory Improvement Amendments (CLIA) guidelines, providing values consistent with hospital blood gas analyzers. - The integration addresses a core architectural challenge in healthcare technology: securely ingesting and analyzing high-velocity, real-time data from medical devices and then connecting it with other hospital information systems for a unified view. - Orrum's CŌRE Registry enables a key function of mature analytics platforms by allowing surgical teams to benchmark their performance on metrics like oxygen delivery and mean arterial blood pressure against anonymized data from other teams. - The partnership reflects a broader trend in cardiac surgery to apply machine learning and predictive analytics to vast datasets from electronic health records and intraoperative devices to create dynamic, real-time clinical decision support tools.